EUVIMEDOpdag EUVIMED
ValidierungsstudieOpen access

Predicting Overall Survival in Patients with Male Breast Cancer: Nomogram Development and External Validation Study

Wen-Zhen Tang iD, Shu-Tian Mo iD, Yuan-Xi Xie iD, Tian-Fu Wei iD, Guo-Lian Chen iD, Yan-Juan Teng iD, Kui Jia iD

JMIR Cancer · 2025

DOI: 10.2196/54625 ↗

At a glance

Validierungsstudie in JMIR Cancer, 2025. Written by Wen-Zhen Tang and 6 co-authors. Institution: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China. Major MEDLINE topics: Nomograms, Breast Neoplasms, Male. Cited 1 times so far (Crossref); 45 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Male breast cancer (MBC) is an uncommon disease. Few studies have discussed the prognosis of MBC due to its rarity.

Objective

This study aimed to develop a nomogram to predict the overall survival of patients with MBC and externally validate it using cases from China.

Methods

Based on the Surveillance, Epidemiology, and End Results (SEER) database, male patients who were diagnosed with breast cancer between January 2010, and December 2015, were enrolled. These patients were randomly assigned to either a training set (n=1610) or a validation set (n=713) in a 7:3 ratio. Additionally, 22 MBC cases diagnosed at the First Affiliated Hospital of Guangxi Medical University between January 2013 and June 2021 were used for external validation, with the follow-up endpoint being June 10, 2023. Cox regression analysis was performed to identify significant risk variables and construct a nomogram to predict the overall survival of patients with MBC. Information collected from the test set was applied to validate the model. The concordance index (C-index), receiver operating characteristic (ROC) curve, decision curve analysis (DCA), and a Kaplan-Meier survival curve were used to evaluate the accuracy and reliability of the model.

Results

A total of 2301 patients with MBC in the SEER database and 22 patients with MBC from the study hospital were included. The predictive model included 7 variables: age (hazard ratio [HR] 1.89, 95% CI 1.50‐2.38), surgery (HR 0.38, 95% CI 0.29‐0.51), marital status (HR 0.75, 95% CI 0.63‐0.89), tumor stage (HR 1.17, 95% CI 1.05‐1.29), clinical stage (HR 1.41, 95% CI 1.15‐1.74), chemotherapy (HR 0.62, 95% CI 0.50‐0.75), and HER2 status (HR 2.68, 95% CI 1.20‐5.98). The C-index was 0.72, 0.747, and 0.981 in the training set, internal validation set, and external validation set, respectively. The nomogram showed accurate calibration, and the ROC curve confirmed the advantage of the model in clinical validity. The DCA analysis indicated that the model had good clinical applicability. Furthermore, the nomogram classification allowed for more accurate differentiation of risk subgroups, and patients with low-risk MBC demonstrated substantially improved survival outcomes compared with medium- and high-risk patients ( P

Subjects

MeSH terms (MEDLINE)

NomogramsBreast Neoplasms, MaleHumansMaleMiddle AgedSEER ProgramAgedPrognosisChinaAdultROC CurveSurvival RateKaplan-Meier EstimateReproducibility of Results

Author keywords

SEER databaseSurveillance, Epidemiology, and End Results databasemale breast cancernomogramprediction modelspecific survival

Authors and institutions

  • Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Department of Central Sterile Supply, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangxi Medical University, No 6 Shuangyong Road, Nanning, 530021, China, +86 0771-12580-6.
  • Department of Medical Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

ORCID profiles: Wen-Zhen Tang, Shu-Tian Mo, Yuan-Xi Xie, Tian-Fu Wei, Guo-Lian Chen, Yan-Juan Teng, Kui Jia

Cite

APA

Tang, W. Z., Mo, S. T., Xie, Y. X., Wei, T. F., Chen, G. L., Teng, Y. J., & Jia, K. (2025). Predicting Overall Survival in Patients with Male Breast Cancer: Nomogram Development and External Validation Study. JMIR Cancer. https://doi.org/10.2196/54625

Vancouver

Tang WZ, Mo ST, Xie YX, Wei TF, Chen GL, Teng YJ, et al. Predicting Overall Survival in Patients with Male Breast Cancer: Nomogram Development and External Validation Study. JMIR Cancer. 2025. doi:10.2196/54625

BibTeX
@article{Tang2025,
  author = {Tang, Wen-Zhen and Mo, Shu-Tian and Xie, Yuan-Xi and Wei, Tian-Fu and Chen, Guo-Lian and Teng, Yan-Juan and Jia, Kui},
  title = {Predicting Overall Survival in Patients with Male Breast Cancer: Nomogram Development and External Validation Study},
  journal = {JMIR Cancer},
  year = {2025},
  doi = {10.2196/54625}
}
Start for free →